This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0020263343 Reproduction Date:
Otenabant (CP-945,598) is a drug which acts as a potent and highly selective CB1 antagonist.[1] It was developed by Pfizer for the treatment of obesity,[2] but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.[3]
M: NUT
cof, enz, met
noco, nuvi, sysi/epon, met
drug (A8/11/12)
Wyeth, New York City, Johnson & Johnson, New York Stock Exchange, Dow Jones Industrial Average
Tetrahydrocannabinol, Cannabidiol, Rimonabant, Anandamide, Am251